Total Payments
$7,675
2024 Payments
$890.35
Companies
33
Transactions
247
Medicare Patients
30,983
Medicare Billing
$3.3M
Payment Breakdown by Category
Food & Beverage$5,428 (70.7%)
Travel$2,072 (27.0%)
Education$174.98 (2.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,428 | 241 | 70.7% |
| Travel and Lodging | $2,072 | 3 | 27.0% |
| Education | $174.98 | 3 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $2,348 | 7 | $0 (2019) |
| Amgen Inc. | $573.93 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $508.38 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $499.86 | 33 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $396.12 | 27 | $0 (2023) |
| Medtronic, Inc. | $354.96 | 7 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $352.34 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $295.55 | 12 | $0 (2024) |
| Boston Scientific Corporation | $291.83 | 4 | $0 (2023) |
| ABIOMED | $289.02 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $890.35 | 44 | SCPHARMACEUTICALS INC. ($153.83) |
| 2023 | $1,317 | 50 | Amgen Inc. ($204.52) |
| 2022 | $948.74 | 38 | ABIOMED ($154.61) |
| 2021 | $653.04 | 23 | BOSTON SCIENTIFIC CORPORATION ($123.95) |
| 2020 | $516.13 | 27 | CHIESI USA, INC. ($115.79) |
| 2019 | $2,569 | 28 | Medtronic Vascular, Inc. ($2,187) |
| 2018 | $613.46 | 26 | Medtronic Vascular, Inc. ($161.03) |
| 2017 | $166.72 | 11 | Amgen Inc. ($66.65) |
All Payment Transactions
247 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $133.93 | General |
| Category: Cardiology | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Cardiology | ||||||
| 09/13/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Not Applicable | ||||||
| 08/29/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.78 | General |
| Category: Cardiovascular | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/19/2024 | WATERMARK MEDICAL, INC. | ARES 620 UNICORDER (Device) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: VENTILATORY EFFORT RECORDER | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.13 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/08/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/02/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Not Applicable | ||||||
| 06/13/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 8,346 | 18,193 | $2.9M | $905,595 |
| 2022 | 44 | 9,417 | 14,103 | $3.2M | $1.0M |
| 2021 | 39 | 7,001 | 10,834 | $2.1M | $746,004 |
| 2020 | 37 | 6,219 | 9,617 | $1.7M | $623,409 |
Total Patients
30,983
Total Services
52,747
Medicare Billing
$3.3M
Procedure Codes
183
All Medicare Procedures & Services
183 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 751 | 753 | $677,051 | $262,952 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 958 | 1,314 | $340,436 | $115,217 | 33.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 660 | 2,648 | $323,850 | $115,113 | 35.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 755 | 766 | $631,570 | $78,993 | 12.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 381 | 382 | $153,739 | $56,733 | 36.9% |
| J1306 | Injection, inclisiran, 1 mg | Office | 2023 | 16 | 5,680 | $136,263 | $53,522 | 39.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 789 | 800 | $115,164 | $37,452 | 32.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 163 | 270 | $64,954 | $26,277 | 40.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 176 | 182 | $63,737 | $25,391 | 39.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 346 | 350 | $47,992 | $17,712 | 36.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 175 | 247 | $39,302 | $16,419 | 41.8% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 26 | 27 | $31,560 | $12,211 | 38.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 830 | 999 | $44,106 | $10,236 | 23.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 44 | 44 | $25,716 | $9,366 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $25,962 | $8,305 | 32.0% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 264 | 710 | $17,935 | $5,881 | 32.8% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 22 | 22 | $16,268 | $5,599 | 34.4% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 26 | 177 | $11,973 | $4,919 | 41.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 723 | 790 | $12,955 | $4,598 | 35.5% |
| 85610 | Blood test, clotting time | Office | 2023 | 283 | 857 | $7,353 | $3,587 | 48.8% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 39 | 44 | $13,911 | $3,467 | 24.9% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 26 | 26 | $12,325 | $3,460 | 28.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 26 | 179 | $9,396 | $3,389 | 36.1% |
| 93455 | Insertion of tube in bypass graft for diagnosis with review by radiologist | Facility | 2023 | 17 | 17 | $9,403 | $3,271 | 34.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $7,562 | $2,935 | 38.8% |
About Mark Treuth
Mark Treuth is a Specialist healthcare provider based in Salisbury, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598757619.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Treuth has received a total of $7,675 in payments from pharmaceutical and medical device companies, with $890.35 received in 2024. These payments were reported across 247 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,428).
As a Medicare-enrolled provider, Treuth has provided services to 30,983 Medicare beneficiaries, totaling 52,747 services with total Medicare billing of $3.3M. Data is available for 4 years (2020–2023), covering 183 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Interventional Cardiology
- Location Salisbury, MD
- Active Since 08/16/2005
- Last Updated 09/11/2019
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1598757619
Products in Payments
- CoreValve Evolut (Device) $2,255
- JARDIANCE (Drug) $496.54
- XARELTO (Drug) $396.12
- LifeVest (Device) $352.34
- ENTRESTO (Drug) $302.81
- Impella (Device) $289.02
- ELIQUIS (Drug) $278.73
- Corlanor (Drug) $239.54
- BRILINTA (Drug) $235.12
- LEQVIO (Drug) $197.05
- Repatha (Biological) $193.89
- FUROSCIX (Drug) $167.98
- WATCHMAN Access System (Device) $167.88
- KENGREAL (Drug) $142.79
- Diamondback Coronary (Device) $132.99
- WATCHMAN (Device) $123.95
- VERQUVO (Drug) $110.33
- LINQ II (Device) $108.33
- COREVALVE EVOLUT R (Device) $101.11
- Reveal LINQ (Device) $97.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Salisbury
Dr. Joseph Cinderella, M.d, M.D
Specialist — Payments: $84,747
Specialist $84,747
Dr. Stephen Keim, M.d, M.D
Specialist — Payments: $31,852
Specialist $31,852
Luette Semmes, M.d, M.D
Specialist — Payments: $21,951
Specialist $21,951
Dr. Jeffrey Etherton, M.d, M.D
Specialist — Payments: $11,203
Specialist $11,203
Dr. Richard Bird, M.d, M.D
Specialist — Payments: $10,619
Specialist $10,619
Dr. Christian Bounds, M.d, M.D
Specialist — Payments: $7,043
Specialist $7,043